Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Inventories, Other : HK$111 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Biocytogen Pharmaceuticals (Beijing) Co's other inventories for the quarter that ended in Dec. 2024 was HK$111 Mil.

Biocytogen Pharmaceuticals (Beijing) Co's quarterly other inventories increased from Dec. 2023 (HK$89 Mil) to Jun. 2024 (HK$101 Mil) and increased from Jun. 2024 (HK$101 Mil) to Dec. 2024 (HK$111 Mil).

Biocytogen Pharmaceuticals (Beijing) Co's annual other inventories increased from Dec. 2022 (HK$85 Mil) to Dec. 2023 (HK$89 Mil) and increased from Dec. 2023 (HK$89 Mil) to Dec. 2024 (HK$111 Mil).

Biocytogen Pharmaceuticals (Beijing) Co Inventories, Other Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co Inventories, Other Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Other

63.83

83.43

85.43

89.38

110.57

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Inventories, Other	Get a 7-Day Free Trial				85.43	99.74	89.38	100.85	110.57

Biocytogen Pharmaceuticals (Beijing) Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Biocytogen Pharmaceuticals (Beijing) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) » Definitions » Inventories, Other

Comparable Companies

Traded in Other Exchanges

I54:Germany

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma, and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC), and other solid tumors.

Executives

Wei Ke Xiang Gang Jing Mao You Xian Gong Si	2101 Beneficial owner
Bvcf Realization Fund, L.p.	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Prowell Ventures Pte Ltd	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Gic Private Limited	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Yang Zhi	2201 Interest of corporation controlled by you
Innoveda Medtech, Ltd.	2201 Interest of corporation controlled by you
Ni Jian
Bvcf Realization Fund Gp, Ltd.	2201 Interest of corporation controlled by you
Bioveda China Fund Ii Rmb, Limited	2101 Beneficial owner
Cmbi Private Equity Series Spc	2201 Interest of corporation controlled by you
Cmb International Private Investment Limited	2201 Interest of corporation controlled by you

Biocytogen Pharmaceuticals (Beijing) Co Headlines

No Headlines